PWPS
SUPN icon

Pinnacle Wealth Planning Services’s Supernus Pharmaceuticals SUPN Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Sell
3,019
-88
-3% -$4.23K 0.01% 697
2026
Q1 		$161K Buy
3,107
+24
+0.8% +$1.22K 0.02% 561
2025
Q4 		$153K Buy
+3,083
New +$150K 0.02% 578
2021
Q1 		– Sell
-51
Closed -$2K – 1743
2020
Q4 		$2K Buy
+51
New +$1.1K ﹤0.01% 1982

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Pinnacle Wealth Planning Services's SUPN Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Supernus Pharmaceuticals (SUPN) stake by 2.8% in Q2 2026, selling an estimated $4.23K and leaving 3,019 shares worth $140K. The position accounts for 0.01% of the portfolio, ranked #697.

Pinnacle Wealth Planning Services first reported a position in SUPN in Q4 2020 and has held it in 4 quarters since. The position peaked at $161K in Q1 2026. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Pinnacle Wealth Planning Services held 3,019 shares of Supernus Pharmaceuticals worth $140K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 88 Supernus Pharmaceuticals shares in Q2 2026, an estimated $4.23K.
  • Supernus Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #697 holding.
  • Pinnacle Wealth Planning Services first reported a position in Supernus Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Supernus Pharmaceuticals position peaked at $161K in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.